Report Detail
Global Angiogenesis Assay Supply, Demand and Key Producers, 2026-2032
- RnM4667062 |
- 22 January, 2026 |
- Global |
- 114 Pages |
- GIR |
- Medical Devices & Consumables
The global Angiogenesis Assay market size is expected to reach $ 43.42 million by 2032, rising at a market growth of 7.3% CAGR during the forecast period (2026-2032).
Angiogenesis is the tightly regulated process by which new blood vessels are formed from the existing vasculature. This process is physiologically important for development and wound healing, and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer. Angiogenesis occurs in response to a variety of molecular cues. Generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however the structures that form during pathological angiogenesis are often functionally abnormal.
The global angiogenesis assay kit market has maintained steady growth in recent years, primarily driven by applications in oncology research, cardiovascular drug development, and organoid models. In terms of technology type, in vitro tube formation experiments dominate, while microfluidic 3D models, embracing the in vivo environment, are experiencing the fastest growth. Regarding pricing, high-end assays maintain high margins thanks to technological barriers, while Chinese manufacturers are rapidly penetrating the mid- and low-end markets through domestic substitution (reducing prices by 30%-50%). Regionally, North America is the largest global market for angiogenesis assay kits, holding over 35% of the market share, followed by Europe and Asia Pacific, which together hold nearly 60% of the market share. Due to cost sensitivity, the Asia Pacific market is seeing an increase in the share of local brands. In the future, as demand for precision medicine and anti-angiogenic drug development increases, highly sensitive, automated assays will become a key competitive focus. Furthermore, price competition in emerging markets is likely to further intensify industry consolidation.
This report studies the global Angiogenesis Assay demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Angiogenesis Assay, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Angiogenesis Assay that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Angiogenesis Assay total market, 2021-2032, (USD Million)
Global Angiogenesis Assay total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Angiogenesis Assay total market, key domestic companies, and share, (USD Million)
Global Angiogenesis Assay revenue by player, revenue and market share 2021-2026, (USD Million)
Global Angiogenesis Assay total market by Type, CAGR, 2021-2032, (USD Million)
Global Angiogenesis Assay total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Angiogenesis Assay market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abcam, Bio-Techne (Trevigen, R&D Systems), Thermo Fisher Scientific, Cell Biolabs, Inc., BioVision, Inc, PromoCell GmbH, Merck KGaA, Kollodis BioSciences, Sartorius (Essen BioScience), Creative Bioarray, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Angiogenesis Assay market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Angiogenesis Assay Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Angiogenesis Assay Market, Segmentation by Type:
In Vitro Assay Kit
In Vivo Assay Kit
Global Angiogenesis Assay Market, Segmentation by Application:
Academic Institution
Biotech Companies
Companies Profiled:
Abcam
Bio-Techne (Trevigen, R&D Systems)
Thermo Fisher Scientific
Cell Biolabs, Inc.
BioVision, Inc
PromoCell GmbH
Merck KGaA
Kollodis BioSciences
Sartorius (Essen BioScience)
Creative Bioarray
ibidi GmbH
Solarbio
Key Questions Answered
1. How big is the global Angiogenesis Assay market?
2. What is the demand of the global Angiogenesis Assay market?
3. What is the year over year growth of the global Angiogenesis Assay market?
4. What is the total value of the global Angiogenesis Assay market?
5. Who are the Major Players in the global Angiogenesis Assay market?
6. What are the growth factors driving the market demand?
1 Supply Summary
- 1.1 Angiogenesis Assay Introduction
- 1.2 World Angiogenesis Assay Market Size & Forecast (2021 & 2025 & 2032)
- 1.3 World Angiogenesis Assay Total Market by Region (by Headquarter Location)
- 1.3.1 World Angiogenesis Assay Market Size by Region (2021-2032), (by Headquarter Location)
- 1.3.2 United States Based Company Angiogenesis Assay Revenue (2021-2032)
- 1.3.3 China Based Company Angiogenesis Assay Revenue (2021-2032)
- 1.3.4 Europe Based Company Angiogenesis Assay Revenue (2021-2032)
- 1.3.5 Japan Based Company Angiogenesis Assay Revenue (2021-2032)
- 1.3.6 South Korea Based Company Angiogenesis Assay Revenue (2021-2032)
- 1.3.7 ASEAN Based Company Angiogenesis Assay Revenue (2021-2032)
- 1.3.8 India Based Company Angiogenesis Assay Revenue (2021-2032)
- 1.4 Market Drivers, Restraints and Trends
- 1.4.1 Angiogenesis Assay Market Drivers
- 1.4.2 Factors Affecting Demand
- 1.4.3 Major Market Trends
2 Demand Summary
- 2.1 World Angiogenesis Assay Consumption Value (2021-2032)
- 2.2 World Angiogenesis Assay Consumption Value by Region
- 2.2.1 World Angiogenesis Assay Consumption Value by Region (2021-2026)
- 2.2.2 World Angiogenesis Assay Consumption Value Forecast by Region (2027-2032)
- 2.3 United States Angiogenesis Assay Consumption Value (2021-2032)
- 2.4 China Angiogenesis Assay Consumption Value (2021-2032)
- 2.5 Europe Angiogenesis Assay Consumption Value (2021-2032)
- 2.6 Japan Angiogenesis Assay Consumption Value (2021-2032)
- 2.7 South Korea Angiogenesis Assay Consumption Value (2021-2032)
- 2.8 ASEAN Angiogenesis Assay Consumption Value (2021-2032)
- 2.9 India Angiogenesis Assay Consumption Value (2021-2032)
3 World Angiogenesis Assay Companies Competitive Analysis
- 3.1 World Angiogenesis Assay Revenue by Player (2021-2026)
- 3.2 Industry Rank and Concentration Rate (CR)
- 3.2.1 Global Angiogenesis Assay Industry Rank of Major Players
- 3.2.2 Global Concentration Ratios (CR4) for Angiogenesis Assay in 2025
- 3.2.3 Global Concentration Ratios (CR8) for Angiogenesis Assay in 2025
- 3.3 Angiogenesis Assay Company Evaluation Quadrant
- 3.4 Angiogenesis Assay Market: Overall Company Footprint Analysis
- 3.4.1 Angiogenesis Assay Market: Region Footprint
- 3.4.2 Angiogenesis Assay Market: Company Product Type Footprint
- 3.4.3 Angiogenesis Assay Market: Company Product Application Footprint
- 3.5 Competitive Environment
- 3.5.1 Historical Structure of the Industry
- 3.5.2 Barriers of Market Entry
- 3.5.3 Factors of Competition
- 3.6 Mergers & Acquisitions Activity
4 United States VS China VS Rest of World (by Headquarter Location)
- 4.1 United States VS China: Angiogenesis Assay Revenue Comparison (by Headquarter Location)
- 4.1.1 United States VS China: Angiogenesis Assay Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
- 4.1.2 United States VS China: Angiogenesis Assay Revenue Market Share Comparison (2021 & 2025 & 2032)
- 4.2 United States Based Companies VS China Based Companies: Angiogenesis Assay Consumption Value Comparison
- 4.2.1 United States VS China: Angiogenesis Assay Consumption Value Comparison (2021 & 2025 & 2032)
- 4.2.2 United States VS China: Angiogenesis Assay Consumption Value Market Share Comparison (2021 & 2025 & 2032)
- 4.3 United States Based Angiogenesis Assay Companies and Market Share, 2021-2026
- 4.3.1 United States Based Angiogenesis Assay Companies, Headquarters (States, Country)
- 4.3.2 United States Based Companies Angiogenesis Assay Revenue, (2021-2026)
- 4.4 China Based Companies Angiogenesis Assay Revenue and Market Share, 2021-2026
- 4.4.1 China Based Angiogenesis Assay Companies, Company Headquarters (Province, Country)
- 4.4.2 China Based Companies Angiogenesis Assay Revenue, (2021-2026)
- 4.5 Rest of World Based Angiogenesis Assay Companies and Market Share, 2021-2026
- 4.5.1 Rest of World Based Angiogenesis Assay Companies, Headquarters (Province, Country)
- 4.5.2 Rest of World Based Companies Angiogenesis Assay Revenue (2021-2026)
5 Market Analysis by Type
- 5.1 World Angiogenesis Assay Market Size Overview by Type: 2021 VS 2025 VS 2032
- 5.2 Segment Introduction by Type
- 5.2.1 In Vitro Assay Kit
- 5.2.2 In Vivo Assay Kit
- 5.3 Market Segment by Type
- 5.3.1 World Angiogenesis Assay Market Size by Type (2021-2026)
- 5.3.2 World Angiogenesis Assay Market Size by Type (2027-2032)
- 5.3.3 World Angiogenesis Assay Market Size Market Share by Type (2027-2032)
6 Market Analysis by Application
- 6.1 World Angiogenesis Assay Market Size Overview by Application: 2021 VS 2025 VS 2032
- 6.2 Segment Introduction by Application
- 6.2.1 Academic Institution
- 6.2.2 Biotech Companies
- 6.3 Market Segment by Application
- 6.3.1 World Angiogenesis Assay Market Size by Application (2021-2026)
- 6.3.2 World Angiogenesis Assay Market Size by Application (2027-2032)
- 6.3.3 World Angiogenesis Assay Market Size Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Abcam
- 7.1.1 Abcam Details
- 7.1.2 Abcam Major Business
- 7.1.3 Abcam Angiogenesis Assay Product and Services
- 7.1.4 Abcam Angiogenesis Assay Revenue, Gross Margin and Market Share (2021-2026)
- 7.1.5 Abcam Recent Developments/Updates
- 7.1.6 Abcam Competitive Strengths & Weaknesses
- 7.2 Bio-Techne (Trevigen, R&D Systems)
- 7.2.1 Bio-Techne (Trevigen, R&D Systems) Details
- 7.2.2 Bio-Techne (Trevigen, R&D Systems) Major Business
- 7.2.3 Bio-Techne (Trevigen, R&D Systems) Angiogenesis Assay Product and Services
- 7.2.4 Bio-Techne (Trevigen, R&D Systems) Angiogenesis Assay Revenue, Gross Margin and Market Share (2021-2026)
- 7.2.5 Bio-Techne (Trevigen, R&D Systems) Recent Developments/Updates
- 7.2.6 Bio-Techne (Trevigen, R&D Systems) Competitive Strengths & Weaknesses
- 7.3 Thermo Fisher Scientific
- 7.3.1 Thermo Fisher Scientific Details
- 7.3.2 Thermo Fisher Scientific Major Business
- 7.3.3 Thermo Fisher Scientific Angiogenesis Assay Product and Services
- 7.3.4 Thermo Fisher Scientific Angiogenesis Assay Revenue, Gross Margin and Market Share (2021-2026)
- 7.3.5 Thermo Fisher Scientific Recent Developments/Updates
- 7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
- 7.4 Cell Biolabs, Inc.
- 7.4.1 Cell Biolabs, Inc. Details
- 7.4.2 Cell Biolabs, Inc. Major Business
- 7.4.3 Cell Biolabs, Inc. Angiogenesis Assay Product and Services
- 7.4.4 Cell Biolabs, Inc. Angiogenesis Assay Revenue, Gross Margin and Market Share (2021-2026)
- 7.4.5 Cell Biolabs, Inc. Recent Developments/Updates
- 7.4.6 Cell Biolabs, Inc. Competitive Strengths & Weaknesses
- 7.5 BioVision, Inc
- 7.5.1 BioVision, Inc Details
- 7.5.2 BioVision, Inc Major Business
- 7.5.3 BioVision, Inc Angiogenesis Assay Product and Services
- 7.5.4 BioVision, Inc Angiogenesis Assay Revenue, Gross Margin and Market Share (2021-2026)
- 7.5.5 BioVision, Inc Recent Developments/Updates
- 7.5.6 BioVision, Inc Competitive Strengths & Weaknesses
- 7.6 PromoCell GmbH
- 7.6.1 PromoCell GmbH Details
- 7.6.2 PromoCell GmbH Major Business
- 7.6.3 PromoCell GmbH Angiogenesis Assay Product and Services
- 7.6.4 PromoCell GmbH Angiogenesis Assay Revenue, Gross Margin and Market Share (2021-2026)
- 7.6.5 PromoCell GmbH Recent Developments/Updates
- 7.6.6 PromoCell GmbH Competitive Strengths & Weaknesses
- 7.7 Merck KGaA
- 7.7.1 Merck KGaA Details
- 7.7.2 Merck KGaA Major Business
- 7.7.3 Merck KGaA Angiogenesis Assay Product and Services
- 7.7.4 Merck KGaA Angiogenesis Assay Revenue, Gross Margin and Market Share (2021-2026)
- 7.7.5 Merck KGaA Recent Developments/Updates
- 7.7.6 Merck KGaA Competitive Strengths & Weaknesses
- 7.8 Kollodis BioSciences
- 7.8.1 Kollodis BioSciences Details
- 7.8.2 Kollodis BioSciences Major Business
- 7.8.3 Kollodis BioSciences Angiogenesis Assay Product and Services
- 7.8.4 Kollodis BioSciences Angiogenesis Assay Revenue, Gross Margin and Market Share (2021-2026)
- 7.8.5 Kollodis BioSciences Recent Developments/Updates
- 7.8.6 Kollodis BioSciences Competitive Strengths & Weaknesses
- 7.9 Sartorius (Essen BioScience)
- 7.9.1 Sartorius (Essen BioScience) Details
- 7.9.2 Sartorius (Essen BioScience) Major Business
- 7.9.3 Sartorius (Essen BioScience) Angiogenesis Assay Product and Services
- 7.9.4 Sartorius (Essen BioScience) Angiogenesis Assay Revenue, Gross Margin and Market Share (2021-2026)
- 7.9.5 Sartorius (Essen BioScience) Recent Developments/Updates
- 7.9.6 Sartorius (Essen BioScience) Competitive Strengths & Weaknesses
- 7.10 Creative Bioarray
- 7.10.1 Creative Bioarray Details
- 7.10.2 Creative Bioarray Major Business
- 7.10.3 Creative Bioarray Angiogenesis Assay Product and Services
- 7.10.4 Creative Bioarray Angiogenesis Assay Revenue, Gross Margin and Market Share (2021-2026)
- 7.10.5 Creative Bioarray Recent Developments/Updates
- 7.10.6 Creative Bioarray Competitive Strengths & Weaknesses
- 7.11 ibidi GmbH
- 7.11.1 ibidi GmbH Details
- 7.11.2 ibidi GmbH Major Business
- 7.11.3 ibidi GmbH Angiogenesis Assay Product and Services
- 7.11.4 ibidi GmbH Angiogenesis Assay Revenue, Gross Margin and Market Share (2021-2026)
- 7.11.5 ibidi GmbH Recent Developments/Updates
- 7.11.6 ibidi GmbH Competitive Strengths & Weaknesses
- 7.12 Solarbio
- 7.12.1 Solarbio Details
- 7.12.2 Solarbio Major Business
- 7.12.3 Solarbio Angiogenesis Assay Product and Services
- 7.12.4 Solarbio Angiogenesis Assay Revenue, Gross Margin and Market Share (2021-2026)
- 7.12.5 Solarbio Recent Developments/Updates
- 7.12.6 Solarbio Competitive Strengths & Weaknesses
8 Industry Chain Analysis
- 8.1 Angiogenesis Assay Industry Chain
- 8.2 Angiogenesis Assay Upstream Analysis
- 8.3 Angiogenesis Assay Midstream Analysis
- 8.4 Angiogenesis Assay Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
- 10.1 Methodology
- 10.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Angiogenesis Assay. Industry analysis & Market Report on Angiogenesis Assay is a syndicated market report, published as Global Angiogenesis Assay Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Angiogenesis Assay market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
